LLNI Funded Publications
Microarray classification of myelodysplastic syndrome (MDS) identifies subgroups with distinct clinical outcomes and identifies patients with high risk of AML transformation
Author:KI Mills
Other Authors: A Kohlmann, PM Williams, L Wieczorek, W-M Liu, R Li, W Wen, DT Bowen, H Loeffler, JM Hernandez, W-K Hofmann, T Haferlach,
Journal:Blood
Date: May 2009
